Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistance.
about
Effects of 3' untranslated region mutations on plus-strand priming during moloney murine leukemia virus replication.Suppression of a fusion defect by second site mutations in the ecotropic murine leukemia virus surface protein.Adaptation of chimeric retroviruses in vitro and in vivo: isolation of avian retroviral vectors with extended host range.A replication-competent feline leukemia virus, subgroup A (FeLV-A), tagged with green fluorescent protein reporter exhibits in vitro biological properties similar to those of the parental FeLV-AHomologous recombination of copackaged retrovirus RNAs during reverse transcriptionReplication-competent retrovirus vectors for the transfer and expression of gene cassettes in avian cells.Construction of a replication-competent murine retrovirus vector expressing the human immunodeficiency virus type 1 tat transactivator protein.Identification of cellular promoters by using a retrovirus promoter trap.Transfer of a mutant dihydrofolate reductase gene into pre- and postimplantation mouse embryos by a replication-competent retrovirus vectorExpression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein.Replication of lengthened Moloney murine leukemia virus genomes is impaired at multiple stages.Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary.Self-deleting retrovirus vectors for gene therapy.Murine leukemia virus-based Tat-inducible long terminal repeat replacement vectors: a new system for anti-human immunodeficiency virus gene therapy.Cre/loxP-mediated excision of a neomycin resistance expression unit from an integrated retroviral vector increases long terminal repeat-driven transcription in human hematopoietic cells.Screening retroviral packaging cells for highly efficient virus production by using a combined selection procedure.Isolation of a chicken gene that confers susceptibility to infection by subgroup A avian leukosis and sarcoma viruses.Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectors.Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells.Excision of an integrated provirus by the action of FLP recombinase.New vectors for gene therapy.
P2860
Q33640102-7B79FC45-8D2E-4A90-A913-4CFBFB96A01AQ33814294-43D25224-9EF6-4BB6-B688-FF87635316ACQ33851610-DEE569B5-446B-4378-A1AD-7E3923C213B5Q33854816-A3540874-AADB-4232-B5C1-54D30DF2D091Q33932573-8DFB5551-DBC0-4051-A09E-5907BA925C00Q36701415-78592347-53BB-48F8-AAC8-DA9084A64C14Q36797468-2D382F49-6C8B-4B8C-98E2-E8031CAEE74DQ36829664-12C903A8-4F8B-4627-A14F-33FC75487E43Q36831724-CAA372E2-17AC-4D3D-8D00-6A316B5B0381Q37526630-03EF9E8E-FDE5-4FB0-908F-B5B2F5C0DDB1Q39589844-191BE9F6-FCB7-403B-BC2B-2DFF59A3B7D7Q39603791-6FE0FC5C-3D1D-477D-B4B9-CA9C98582663Q39875395-7E548A4D-9231-47B2-8F24-ED87DADDA6D3Q39877082-0D204D9B-A631-4E8F-9152-4E44DED01371Q39881411-A3FEE360-A353-41E2-8CA3-3D9943605623Q40038005-A688C49F-137A-42C0-9D79-9C5F0DB9787BQ40061194-3D272592-69C9-4553-BD95-2227A8DDC388Q40144043-56CAED1A-6FA4-4384-82F9-5A41F33F990EQ40461869-265AA0D2-7AC8-4598-A958-0F3A948FBC2CQ42832459-0E2F33EF-DF1D-478A-BAC1-EAFA8B572E94Q45871144-DBAE55DC-D2E0-413B-A99F-808B9D3C6450
P2860
Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistance.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Construction and properties of ...... oding methotrexate resistance.
@en
type
label
Construction and properties of ...... oding methotrexate resistance.
@en
prefLabel
Construction and properties of ...... oding methotrexate resistance.
@en
P2093
P2860
P356
P1476
Construction and properties of ...... oding methotrexate resistance.
@en
P2093
H Stuhlmann
R C Mulligan
R Jaenisch
P2860
P304
P356
10.1128/MCB.9.1.100
P407
P577
1989-01-01T00:00:00Z